Drug Company Bribes and Illegal Kickbacks: SEC Bounty Actions and DOJ Qui Tam Actions Offer Large Rewards to Whistleblowers that Expose Drug Maker Bribes and Illegal Kickbacks by Drug Company Bribe Lawyer and Drug Company Illegal Kickback Lawyer

The SEC Is Offering Large Financial Rewards to Whistleblowers That Expose Drug Procurement Illegal Kickbacks, Drug Contract Bribes, and Violations of the Foreign Corrupt Practices Act by Drug Company Bribe Lawyer, Drug Contract Bribe Lawyer, and Drug Company Illegal Kickback Whistleblower Lawyer Jason S. Coomer

Whistleblowers and international whistleblowers can recover large amounts of money for exposing drug company bribes, international medicine procurement kickbacks, drug contract bribes, and other violations of the Foreign Corrupt Practices Act, Federal False Claims Act, and State Medicaid Fraud Recovery Laws.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of drug company bribes, drug company fraud, international drug company bribes, international pharmaceutical company illegal kickback schemes, public health medicine procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, medication, pharmaceutical, and medical equipment contracts are encouraged to blow the whistle on such corrupt practices.  These whistleblowers are being offered large financial rewards and strong whistleblower protections. 

 
Drugmaker Teva subpoenaed by SEC over antibribery compliance | Reuters

 "Israel's Teva Pharmaceutical Industries , the world's biggest generic-drug maker, is being investigated by the U.S. securities regulator over the company's compliance with a U.S. law that prohibits bribery of foreign officials.  In a filing with the U.S. Securities and Exchange Commission last week, Teva said it had received a subpoena dated July 9 to produce documents in connection with its business practices in Latin America."

"The SEC's move is part of a wider probe into the drug industry for possible violations of the Foreign Corrupt Practices Act, as major drugmakers look to expand in emerging markets.   A Reuters examination of U.S. SEC filings by the world's top 10 drug companies has found that at least eight of them had warned of potential costs related to charges of corruption in overseas markets."

"Early this year, Bristol-Myers Squibb Co said it had received a subpoena from SEC regarding its sales and marketing practices in various foreign countries.  Last year, Johnson & Johnson agreed to pay $70 million to settle U.S. charges that it paid bribes and kickbacks to win business in Greece, Iraq, Poland and Romania, in the first such settlement by a big drug company."
The International Federation of Pharmaceutical Manufacturers and Associations said early this year it had expanded and strengthened the code to ensure "the highest ethical and professional standards".

Drug Bribe Whistleblower Lawsuit Information, Drug Procurement Contract Bribe Lawsuit Information, and Drug Company Illegal Kickback Whistleblower Lawsuit Information

For more information on a potential Foreign Corrupt Practices Act Drug Bribe Whistleblower Reward Lawsuits and Drug Company Fraud Lawsuits, please  please feel free to send an e-mail message to International Drug Company Fraud Whistleblower Lawyer and International Drug Company Illegal Bribe Whistleblower Lawyer Jason Coomer or go to the following web page: International Drug Procurement Bribe Whistleblower Lawsuits and Health Care Drug Procurement Fraud Lawsuits.